{"entity":{"type":"insider","cik":"0001688192","url":"/insider/0001688192","json_url":"/insider/0001688192.json","name":"Treco Douglas A","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2024-04-03","last":"2025-08-08","span_basis":"filed_date"},"name_variants":[{"name":"Treco Douglas A","source":"filing","n_filings":3,"first_seen":"2024-04-03","last_seen":"2025-08-08"}],"transactions":[{"id":5115432,"accession":"0001688192-25-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001688192-25-000004","line_url":"/filing/0001688192-25-000004#line-1","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001688192","owner_name":"Treco Douglas A","owner_display_name":"Treco Douglas A","owner_url":"/insider/0001688192","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":57.03,"price_display":"57.03","price_state":"stated","total_value":1140600.0,"total_display":"1,140,600.00","total_whole":"1,140,600","shares_owned_after":22000.0,"shares_owned_after_display":"22,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-06","filed_date":"2025-08-08","scope":"insider"},{"id":5074396,"accession":"0000950170-25-050443","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-050443","line_url":"/filing/0000950170-25-050443#line-2","is_derivative":false,"issuer_cik":"0001688192","issuer_name":"Inozyme Pharma, Inc.","issuer_ticker":"INZY","issuer_name_source":null,"issuer_url":"/issuer/0001688192","owner_cik":"0001688192","owner_name":"Treco Douglas A","owner_display_name":"Treco Douglas A","owner_url":"/insider/0001688192","role":"Director, Officer (CEO & Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8819.0,"shares_display":"8,819","price_per_share":0.89,"price_display":"0.89","price_state":"stated","total_value":7848.91,"total_display":"7,848.91","total_whole":"7,849","shares_owned_after":41046.0,"shares_owned_after_display":"41,046","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-02","filed_date":"2025-04-03","scope":"insider"},{"id":3214337,"accession":"0000950170-24-041301","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-041301","line_url":"/filing/0000950170-24-041301#line-2","is_derivative":false,"issuer_cik":"0001688192","issuer_name":"Inozyme Pharma, Inc.","issuer_ticker":"INZY","issuer_name_source":null,"issuer_url":"/issuer/0001688192","owner_cik":"0001688192","owner_name":"Treco Douglas A","owner_display_name":"Treco Douglas A","owner_url":"/insider/0001688192","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7523.0,"shares_display":"7,523","price_per_share":6.94,"price_display":"6.94","price_state":"stated","total_value":52209.62,"total_display":"52,209.62","total_whole":"52,210","shares_owned_after":20665.0,"shares_owned_after_display":"20,665","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-02","filed_date":"2024-04-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001674416","name":"CRISPR Therapeutics AG","url":"/issuer/0001674416","role":"Director","n_filings":1,"first_seen":"2025-08-08","last_seen":"2025-08-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001693011","name":"Inozyme Pharma, Inc.","url":"/issuer/0001693011","role":"Director, Officer (CEO & Chairman)","n_filings":2,"first_seen":"2024-04-03","last_seen":"2025-04-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001688192","retrieved_at":"2026-08-26T14:27:37+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}